taurolidine has been researched along with B cepacia Infection in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasan, MA; Lange, CF | 1 |
| Cowperthwaite, C; Gallagher, MJ; Hart, CA; Ledson, MJ; Robinson, M; Walshaw, MJ; Williets, T | 1 |
2 trial(s) available for taurolidine and B cepacia Infection
| Article | Year |
|---|---|
Estimating in vivo airway surface liquid concentration in trials of inhaled antibiotics.
Topics: Administration, Inhalation; Aerosols; Anti-Bacterial Agents; Burkholderia cepacia; Burkholderia Infections; Computer Simulation; Cystic Fibrosis; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Models, Biological; Nebulizers and Vaporizers; Particle Size; Pseudomonas aeruginosa; Pseudomonas Infections; Research Design; Respiratory Mechanics; Respiratory System; Sputum; Taurine; Thiadiazines; Tobramycin | 2007 |
A randomized double-blinded placebo-controlled crossover trial of nebulized taurolidine in adult cystic fibrosis patients infected with Burkholderia cepacia.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Burkholderia cepacia; Burkholderia Infections; Colony Count, Microbial; Cross-Over Studies; Cystic Fibrosis; Double-Blind Method; Drug Resistance, Microbial; Female; Humans; Male; Nebulizers and Vaporizers; Prospective Studies; Spirometry; Sputum; Taurine; Thiadiazines; Treatment Outcome | 2002 |